{"name":"Barinthus Biotherapeutics","slug":"barinthus-biotherapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":25564000,"netIncome":-66428000,"cash":98169000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"date":"2026-03-31","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1WR0E2eF92cXBwVGRMSHJfYVZ2U1EzTjBYVVVqMHBCV0JzWElqRDNWZ0NaZ3BNMVltd0JIa3ZlOVc4a2pfUXZOXzJZdkxuYjlqa0lITTRCOGJuUEZSZlBPYi1oN2Fhd1VSVVFBc0Zn?oc=5","date":"2026-03-22","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in Barinthus Biotherapeutics plc (BRNS) - Stock Titan","headline":"If You Invested $1,000 in Barinthus Biotherapeutics plc (BRNS)","sentiment":"neutral"},{"date":"2026-03-13","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-13","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-02-23","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2026-01-06","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-12-10","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-11-07","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2025-11-07","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxQRmlBeDluYjlUMjdtcW9IbjZEN1lwTVBHUnh1c1lNSFZTek5iSTA2QWZUY0tfQnVIb25GZWFlWWZZT2JLLTBGQ3hYQldpeGhHT3lwaUZlRXd0TG54enk4cEExZnBqLXl3NFJzaklVQWY5aHFacmZ6MF9zcUlaVVRXMllSWVZ5ZC1MYkpqUm84bTVUU2M0cl9BV1dUZ2lpejNMc0FadG9TR09UQ1VSMnlWdVlmR05QVDk1R0lfX2VHaGNGYllvT2JSZURDRlNOZkRjUEY2LUdZN1BpZ2YyOEVOYVVBRFJhY041NUotLUNtb05xTHVQd0d3dWpTM2p6dm1DLTM0S0FqZk1Td3M?oc=5","date":"2025-09-30","type":"pipeline","source":"GlobeNewswire","summary":"Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases - GlobeNewswire","headline":"Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases","sentiment":"neutral"},{"date":"2025-09-30","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2025-08-07","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2025-08-07","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxQdlNxWkYzZUNkZjM3Tl9JakdiX1VJQ2p0eHpxaDN0REVKZDZNWERUNnI0aU5SZS12UWtnbnk5Y0RBYk9VSlVxS01YMTlteTlSM3JiS1RLOXdVdWJhVmNHbXVHUEJkUzI5eDVOcGhtUFkzTXprSVJWeGlEZUJnS3hvMkoxTkVmbExIYnAwMk44dXJoVjlyS0FyT2RSY3RJZnVzUG9pNDF3YmhwcUk2aHQ1akZIa0pURnlFN3g5OFBGcUVLN1pjc1h4TUxlS1AyQmhCUjl1Q2JNTG5maVMyZEFLcl9ubXFKeE53VXYyZk9NVdIB9AFBVV95cUxNUXZGNWVGTnl4VFQwRkxBMGczY0w0NUdWY0ptRnpDQ0U3Y2dVWFI0MV8xR1NzVnF3M2tUYV9kMTh2NmIyNmphSXhMU0tnOFpPSjFKQkxDU3p0S0NSMG4zQVhFM2IyUkpjZFQ2NHpxMFd4NUhNVFVfV3EyYnlyOEh4YmVYbjBtZ0ZIMWVJOENFOC1meEN1blgxa3Q5Z3RtY01FWFl4WDJYQXB4SUdKRWQySjY3V0JtaGVVRVNQN1g5YVcwTHR2NHQ5ZDJBeG56T1NPVGJvZDNISmE2RkM4Z2l4N3dXNVhndVZkUFJzc3E2ekZUaVZP?oc=5","date":"2025-06-22","type":"earnings","source":"simplywall.st","summary":"Improved Revenues Required Before Barinthus Biotherapeutics plc (NASDAQ:BRNS) Stock's 29% Jump Looks Justified - simplywall.st","headline":"Improved Revenues Required Before Barinthus Biotherapeutics plc (NASDAQ:BRNS) Stock's 29% Jump Looks Justified","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigJBVV95cUxQZlFEVUVTcV83c1BCb3JVLVJuNk9qY3NQS1F0Znd5OXlLMXp5RlhnNFBYYlNNaHBicmJ1REhabFNBUjlGRGNtVm16cVlBQ18tRmpBS0JqaGp3YUpmTDc0VTA0VXZFemE3N2xEam9XQk5SSHNLak9Mbk5TRmNPWWVsTi1zbnRQOVF6TS1mWklmTXBEdzZJNm5yTVFPVVExVVVkUnFpYmEtQUFGZGQ1b2I4NEhlYnlhblp5dG1NSHByWkNaS0J3MWhFbWw4T0VlZlBYMFhVLUd1MHY3MGEzT1J6Yk1rQ2pCT1AzWVJTaHF2QXBmeFRTNzZwek5MclNleGZQSERVT002NXZCZw?oc=5","date":"2025-01-10","type":"pipeline","source":"GlobeNewswire","summary":"Barinthus Bio Announces Strategic Focus in Immunology and Inflammation (I&I) and Provides a Financial Update - GlobeNewswire","headline":"Barinthus Bio Announces Strategic Focus in Immunology and Inflammation (I&I) and Provides a Financial Update","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":0,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":0,"period":"2025-12-31"},{"value":14969000,"period":"2024-12-31"},{"value":14969000,"period":"2024-12-31"},{"value":802000,"period":"2023-12-31"},{"value":802000,"period":"2023-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":25564000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-66428000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":98169000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}